K - BLADDER FUNCTION
All individuals with SCI and evidence of neurogenic bladders should ideally be assessed using video urodynamic as it is the gold standard to assess neurogenic lower urinary tract in individuals with SCI. (URO 2017, p.589; Level A)
Attending clinicians should not stop medications that may influence lower tract function before video urodynamic; however, their administration should be considered in the interpretation of the data. (URO 2017, p.589; Level B)
Clinicians should not routinely prescribe antibiotic prophylaxis before urodynamics. However, in scenarios where the individual has high-risk factors such as, evidence of vesicoureteral reflux, high voiding pressure, repeated urinary tract infection or prothesis that may be at risk of infection, antibiotic prophylaxis may be considered prior to urodynamics. (Adapted from URO 2017, p.589; Level C)
Urodynamic studies should not be performed when an individual with SCI has a symptomatic UTI or pyuria to avoid worsening of the clinical condition and prevent erroneous interpretation of the urodynamic findings. (Adapted from URO 2017, p.589; Level C)